paclitaxel (proliposomal intravesical formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for paclitaxel (proliposomal intravesical formulation), covering 2025-06-13 to 2025-06-13. Get the full timeline:
Most recent: Clinical Trial Update: Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer [Phase 1, Phase 2]